Cardiovascular flow enhancer and method of operation

Claim 3

The method of implanting a cardiovascular flow enhancer as claimed in claim 1 wherein the outlet conduit is connected with the descending thoracic aorta at substantially the last blood flow and pressure antinode before the heart of the descending thoracic aorta.

Claim 4

The method of implanting a cardiovascular flow enhancer as claimed in claim 1 in which the pump is located above the diaphragm in the lower left hemithorax of the posterior chest.

Claim 5

The method of implanting a cardiovascular flow enhancer as claimed in claim 1 in which the pump is located in the upper left hemithorax of the posterior chest.

Claim 8

The method of implanting a cardiovascular flow enhancer as claimed in claim 5 wherein a section of the thoracic aorta is connected in shunt with the pump.

Claim 9

The method of implanting a cardiovascular flow enhancer as claimed in claim 5 further comprising providing a controllable occluder operatively associated with the alternate flow path, the occluder being operable to minimize blood flow through the flow path in shunt with the pump during normal operation of the pump and to allow greater blood flow through the shunt conduit when blood flow through the pump falls below a minimum level.

Claim 10

The method of implanting a cardiovascular flow enhancer as claimed in claim 5 wherein the alternate flow path comprises an expandable graft conduit having an inner diameter permitting minimal blood flow through the shunt conduit when the pump is in normal operation, the expandable graft conduit being expandable to allow greater blood flow through the conduit when blood flow through the pump falls below a minimum level.

Claim 11

The method of implanting a cardiovascular flow enhancer as claimed in claim 5 wherein the alternate flow path includes a check valve to prevent back flow through the alternate flow path, and wherein the check valve is openable to allow blood flow through the alternate flow path when pressure upstream of the check valve reaches a predetermined maximum level.

Claim 16

The method of implanting a cardiovascular flow enhancer as claimed in claim 11 wherein the pump inlet is connected to receive blood from a site about one to twelve centimeters downstream from the juncture of the left subclavian artery and the aorta.

Claim 19

The method of improving cardiovascular performance of claim 13 further comprising: providing an inlet conduit having one end in fluid communication with the pump inlet; providing an outlet conduit having one end in fluid communication with the pump outlet; connecting the other end of the inlet conduit to the descending thoracic aorta substantially at the first nodal point; and connecting the other end of the outlet conduit to the descending thoracic aorta at a point downstream of the connection of the inlet conduit to the descending thoracic aorta.

Claim 20

The method of improving cardiovascular performance of claim 14 further comprising providing an inlet chamber in fluid connection with the pump inlet and the inlet conduit, an outlet chamber in fluid communication with the outlet conduit and the pump outlet, and a housing holding the pump, inlet chamber and outlet chamber.

Claim 21

The method of improving cardiovascular performance of claim 15 further comprising providing an emergency shunt flow path between the inlet chamber and the outlet chamber, the emergency shunt flow path being held within said housing.

Claim 22

The method of improving cardiovascular performance of claim 15 further comprising providing a drive motor within the housing to drive the pump.

Claim 23

The method of improving cardiovascular performance of claim 13 further comprising the steps of: sensing physiological conditions of the subject; and varying pump speed in accordance with the sensed physiological conditions of the subject.

Claim 24

A cardiovascular flow enhancer comprising: a centrifugal pump having an inlet and an outlet; an inlet conduit having one end in fluid communication with the pump inlet; an outlet conduit having one end in fluid communication with the pump outlet; the centrifugal pump, inlet conduit and outlet conduit defining a primary blood flow path; and a parallel flow conduit extending between the inlet and outlet conduits to provide an emergency blood flow path for a level of blood flow when blood flow through the pump falls below a minimum level and to provide a secondary blood flow path for a lower level of blood flow during normal operation of the pump, the parallel flow conduit being in parallel with the primary blood flow path the cardiovascular flow enhancer further comprising a housing made of a biologically inert material within which the centrifugal pump and parallel flow conduit are held, said housing being configured and sized to be implanted in a living body.

Claim 25

A cardiovascular flow enhancer comprising: a centrifugal pump having an inlet and an outlet; an inlet conduit having one end in fluid communication with the pump inlet; an outlet conduit having one end in fluid communication with the pump outlet; the centrifugal pump, inlet conduit and outlet conduit defining a primary blood flow path; and a parallel flow conduit extending between the inlet and outlet conduits to provide an emergency blood flow path for a level of blood flow when blood flow through the pump falls below a minimum level and to provide a secondary blood flow path for a lower level of blood flow during normal operation of the pump, the parallel flow conduit being in parallel with the primary blood flow path the cardiovascular flow enhancer further comprising a housing made of a biologically inert material within which the centrifugal pump and parallel flow conduit are held, said housing being configured and sized to be implanted in a living body.

Claim 26

The cardiovascular flow enhancer of claim 19 further comprising a controllable occluder operatively associated with the parallel flow conduit to limit blood flow through the parallel flow conduit during normal operation of the pump and to allow greater blood flow through the parallel flow conduit when blood flow through the pump falls below a minimum level.

Claim 27

The cardiovascular flow enhancer of claim 19 wherein the parallel flow conduit is expandable and has an inner diameter permitting minimal blood flow through the shunt conduit when the pump is in normal operation, the parallel flow conduit being expandable to allow greater blood flow through the conduit when blood flow through the pump falls below a minimum level.

Claim 28

The cardiovascular flow enhancer of claim 19 further comprising a flap valve to limit blood flow through the parallel flow conduit, the flap valve being openable to allow blood flow through the parallel flow conduit when pressure upstream of the flap valve reaches a predetermined maximum level.

Claim 29

The cardiovascular flow enhancer of claim 19 wherein the inlet conduit defines an inlet chamber in fluid communication with the pump inlet and the outlet conduit defines an outlet chamber in fluid communication with the pump outlet, the inlet and outlet chambers being held within the housing and the parallel flow conduit extending between the inlet chamber and the outlet chamber.